308 related articles for article (PubMed ID: 31296155)
1. Inflammation as the Common Biological Link Between Depression and Cardiovascular Diseases: Can Carnosine Exert a Protective Role?
Caruso G; Fresta CG; Grasso M; Santangelo R; Lazzarino G; Lunte SM; Caraci F
Curr Med Chem; 2020; 27(11):1782-1800. PubMed ID: 31296155
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-Associated Co-morbidity Between Depression and Cardiovascular Disease.
Halaris A
Curr Top Behav Neurosci; 2017; 31():45-70. PubMed ID: 27830572
[TBL] [Abstract][Full Text] [Related]
3. Co-morbidity between cardiovascular pathology and depression: role of inflammation.
Halaris A
Mod Trends Pharmacopsychiatry; 2013; 28():144-61. PubMed ID: 25224897
[TBL] [Abstract][Full Text] [Related]
4. Microfluidic/HPLC combination to study carnosine protective activity on challenged human microglia: Focus on oxidative stress and energy metabolism.
Privitera A; Cardaci V; Weerasekara D; Saab MW; Diolosà L; Fidilio A; Jolivet RB; Lazzarino G; Amorini AM; Camarda M; Lunte SM; Caraci F; Caruso G
Front Pharmacol; 2023; 14():1161794. PubMed ID: 37063279
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen Sulfide and Carnosine: Modulation of Oxidative Stress and Inflammation in Kidney and Brain Axis.
Calabrese V; Scuto M; Salinaro AT; Dionisio G; Modafferi S; Ontario ML; Greco V; Sciuto S; Schmitt CP; Calabrese EJ; Peters V
Antioxidants (Basel); 2020 Dec; 9(12):. PubMed ID: 33353117
[TBL] [Abstract][Full Text] [Related]
6. Inflammation, heart disease, and depression.
Halaris A
Curr Psychiatry Rep; 2013 Oct; 15(10):400. PubMed ID: 23975043
[TBL] [Abstract][Full Text] [Related]
7. Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress.
Caruso G; Benatti C; Musso N; Fresta CG; Fidilio A; Spampinato G; Brunello N; Bucolo C; Drago F; Lunte SM; Peterson BR; Tascedda F; Caraci F
Biomedicines; 2021 Apr; 9(5):. PubMed ID: 33926064
[TBL] [Abstract][Full Text] [Related]
8. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients.
Maes M; Ruckoanich P; Chang YS; Mahanonda N; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):769-83. PubMed ID: 20561554
[TBL] [Abstract][Full Text] [Related]
9. Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology for Treating Cognitive Deficits, Depression and Intellectual Disabilities.
Babizhayev MA
Curr Pharm Biotechnol; 2014; 15(8):738-78. PubMed ID: 25158972
[TBL] [Abstract][Full Text] [Related]
10. Carnosine Decreases PMA-Induced Oxidative Stress and Inflammation in Murine Macrophages.
Caruso G; Fresta CG; Fidilio A; O'Donnell F; Musso N; Lazzarino G; Grasso M; Amorini AM; Tascedda F; Bucolo C; Drago F; Tavazzi B; Lazzarino G; Lunte SM; Caraci F
Antioxidants (Basel); 2019 Aug; 8(8):. PubMed ID: 31390749
[TBL] [Abstract][Full Text] [Related]
11. An "enigmatic" L-carnosine (β-alanyl-L-histidine)? Cell proliferative activity as a fundamental property of a natural dipeptide inherent to traditional antioxidant, anti-aging biological activities: balancing and a hormonally correct agent, novel patented oral therapy dosage formulation for mobility, skeletal muscle power and functional performance, hypothalamic-pituitary- brain relationship in health, aging and stress studies.
Babizhayev MA; Yegorov YE
Recent Pat Drug Deliv Formul; 2015; 9(1):1-64. PubMed ID: 25524476
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic potential of carnosine: Focus on cellular and molecular mechanisms.
Caruso G; Di Pietro L; Cardaci V; Maugeri S; Caraci F
Curr Res Pharmacol Drug Discov; 2023; 4():100153. PubMed ID: 37441273
[TBL] [Abstract][Full Text] [Related]
13. Physiological and therapeutic effects of carnosine on cardiometabolic risk and disease.
Baye E; Ukropcova B; Ukropec J; Hipkiss A; Aldini G; de Courten B
Amino Acids; 2016 May; 48(5):1131-49. PubMed ID: 26984320
[TBL] [Abstract][Full Text] [Related]
14. Novel therapeutic approaches in limiting oxidative stress and inflammation.
Spychalowicz A; Wilk G; Śliwa T; Ludew D; Guzik TJ
Curr Pharm Biotechnol; 2012 Oct; 13(13):2456-66. PubMed ID: 22280420
[TBL] [Abstract][Full Text] [Related]
15. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
Babizhayev MA; Kasus-Jacobi A
Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, depression and cardiovascular disease in women: the role of the immune system across critical reproductive events.
Mattina GF; Van Lieshout RJ; Steiner M
Ther Adv Cardiovasc Dis; 2019; 13():1753944719851950. PubMed ID: 31144599
[TBL] [Abstract][Full Text] [Related]
17. Novel Insight into Neuroimmune Regulatory Mechanisms and Biomarkers Linking Major Depression and Vascular Diseases: The Dilemma Continues.
Tonhajzerova I; Sekaninova N; Bona Olexova L; Visnovcova Z
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230840
[TBL] [Abstract][Full Text] [Related]
18. Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease.
Schroecksnadel K; Frick B; Winkler C; Fuchs D
Curr Vasc Pharmacol; 2006 Jul; 4(3):205-13. PubMed ID: 16842138
[TBL] [Abstract][Full Text] [Related]
19. Unfolding the mechanism of cisplatin induced pathophysiology in spleen and its amelioration by carnosine.
Banerjee S; Sinha K; Chowdhury S; Sil PC
Chem Biol Interact; 2018 Jan; 279():159-170. PubMed ID: 29191451
[TBL] [Abstract][Full Text] [Related]
20. Cytokine dysregulation, inflammation and well-being.
Elenkov IJ; Iezzoni DG; Daly A; Harris AG; Chrousos GP
Neuroimmunomodulation; 2005; 12(5):255-69. PubMed ID: 16166805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
